Multiroute administration of Wharton’s jelly mesenchymal stem cells in chronic complete spinal cord injury: A phase I safety and feasibility study

Table 2 Study population

Characteristic		n	%
Age, years	19	1	16.7
	20	1	16.7
	29	3	50.0
	39	1	16.7
Sex	Female	1	16.7
	Male	5	83.3
Cause of SCI	Fell from tree	1	16.7
	Firearm injury	2	33.3
	Ski accident	1	16.7
	Traffic accident	2	33.3
Level of injury	T11 burst fracture	1	16.7
	T12 burst fracture with T11-T12 and T12-L1 traumatic disc herniations	1	16.7
	T12 burst fracture with dislocation	1	16.7
	T5 burst fracture	1	16.7
	T7-8 burst fracture	1	16.7
	T8-9 burst fracture	1	16.7
Pre-transplantation treatments	Only physiotherapy	3	50.0
	T11 laminectomy + physiotherapy	1	16.7
	T12 corpectomy + posterior instrumentation + laminectomy + physiotherapy	1	16.7
	T12 corpectomy + posterior instrumentation + laminectomy + physiotherapy	1	16.7
Comorbidity	None	6	100.0
Duration of SCI and first transplantation	6 months	1	16.7
	9 months	2	33.3
	12 months	1	16.7
	4 years	1	16.7
	12 years	1	16.7

SCI: Spinal cord injury.